European Journal of Cancer
Volume 39, Issue 13 , Pages 1948-1956, September 2003

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

  • L Manenti

      Affiliations

    • Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, via Gavazzeni 11, 24125 Bergamo, Italy
  • ,
  • P Paganoni

      Affiliations

    • Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, via Gavazzeni 11, 24125 Bergamo, Italy
  • ,
  • I Floriani

      Affiliations

    • Laboratory of Clinical Research in Oncology, Department of Oncology, Mario Negri Institute for Pharmacological Research, 20157 Milano, Italy
  • ,
  • F Landoni

      Affiliations

    • Department of Gynecological Oncology, Università degli Studi di Milano-Bicocca, Ospedale San Gerardo dei Tintori, 20052 Monza, Italy
  • ,
  • V Torri

      Affiliations

    • Laboratory of Clinical Research in Oncology, Department of Oncology, Mario Negri Institute for Pharmacological Research, 20157 Milano, Italy
  • ,
  • A Buda

      Affiliations

    • Department of Gynecological Oncology, Università degli Studi di Milano-Bicocca, Ospedale San Gerardo dei Tintori, 20052 Monza, Italy
  • ,
  • G Taraboletti

      Affiliations

    • Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, via Gavazzeni 11, 24125 Bergamo, Italy
  • ,
  • R Labianca

      Affiliations

    • Division of Medical Oncology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy
  • ,
  • D Belotti

      Affiliations

    • Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, via Gavazzeni 11, 24125 Bergamo, Italy
  • ,
  • R Giavazzi

      Affiliations

    • Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, via Gavazzeni 11, 24125 Bergamo, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-035-319888; fax: +39-035-319331

Received 28 October 2002; received in revised form 5 February 2003; accepted 13 February 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(03)00427-1

doi:10.1016/S0959-8049(03)00427-1

European Journal of Cancer
Volume 39, Issue 13 , Pages 1948-1956, September 2003